Skip to main content
Caplight Logo









Carcinotech

Carcinotech

Private
EdinburghHealthcare & Life Scienceshttps://www.carcinotech.com/

Last Round

Early Funding

Jan 29, 2024

Total Funding Raised

$7.4M

Company Overview

Carcinotech is a medical technology company that provides 3D printed living tumors using patient-derived biopsies for drug screening, pre-clinical testing, and personalized medicine.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, 3D Printing, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

3D bioprintingtumor modelscontract research organizationCROoncology drug discoverypreclinical testingpersonalized medicineorgan-on-a-chipin vitro modelsdrug screeningtumor microenvironmentpatient-derived cellsbiotech servicestranslational researchlab-on-a-chip

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Carcinotech Comparables

Compare Carcinotech with similar companies based on industry and business-model similarity.

Carcinotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cypre Inc.
88%
TissueTinker Bio
84%
Keliomics
82%

Carcinotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingJan 29, 2024
SeedApr 25, 2022

Key People

Founding team and executive leadership

Lorna Peers FCCA

Chief Financial Officer

Executive Team

Carcinotech Investors

Notable investors and investment history

Carcinotech investors
InvestorRounds
Investing Women AngelsEarly Funding
Gabriel Investments LtdEarly Funding, Seed
British Business BankEarly Funding
Old College CapitalEarly Funding, Pre Seed
The TRICAPITAL SyndicateEarly Funding, Seed
Eos AdvisorySeed, Early Funding
Gabriel InvestmentsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 39% MoM.

  • Jan 29, 2024

    $5.3M raised, led by Eos Advisory.

Carcinotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Carcinotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Carcinotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersEdinburgh
Employee Range11
Year Founded2018
Last FundingJan 29, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?